Aclaris Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BML CAPITAL MANAGEMENT, LLC | 05/06/2026 | 14.25 M | $53.44 M | 0.00% | 11.62% |
| DEEP TRACK CAPITAL, LP | 05/15/2026 | 9.35 M | $35.04 M | 100.00% | 7.62% |
| BLACKROCK, INC. | 05/13/2026 | 7.41 M | $27.78 M | 8.85% | 6.04% |
| RA CAPITAL MANAGEMENT, L.P. | 05/15/2026 | 6.80 M | $25.52 M | 100.00% | 5.55% |
| VIVO CAPITAL, LLC | 05/20/2026 | 6.67 M | $25.00 M | -25.00% | 5.43% |
| 05/15/2026 | 5.17 M | $19.38 M | 100.00% | 4.21% | |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 05/15/2026 | 4.93 M | $18.47 M | 100.00% | 4.02% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 05/15/2026 | 4.47 M | $16.77 M | 0.42% | 3.65% |
| DECHENG CAPITAL LLC | 05/13/2026 | 4.04 M | $15.16 M | 0.00% | 3.29% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2026 | 3.87 M | $14.52 M | 14.83% | 3.16% |
| BALYASNY ASSET MANAGEMENT L.P. | 05/15/2026 | 3.36 M | $12.60 M | 100.00% | 2.74% |
| MORGAN STANLEY | 05/15/2026 | 2.75 M | $10.30 M | -19.59% | 2.24% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 2.42 M | $9.09 M | 1.29% | 1.98% |
| CITADEL ADVISORS LLC | 05/15/2026 | 2.25 M | $8.43 M | 86.62% | 1.83% |
| STATE STREET CORP | 05/15/2026 | 2.01 M | $7.53 M | 33.35% | 1.64% |
| 05/15/2026 | 1.83 M | $6.87 M | 100.00% | 1.49% | |
| BRAIDWELL LP | 05/15/2026 | 1.70 M | $6.37 M | 100.00% | 1.39% |
| 05/08/2026 | 1.66 M | $6.21 M | 100.00% | 1.35% | |
| PALO ALTO INVESTORS LP | 05/15/2026 | 1.61 M | $6.05 M | 2.97% | 1.32% |
| ACADIAN ASSET MANAGEMENT LLC | 05/13/2026 | 1.54 M | $5.77 M | -27.45% | 1.26% |
| WOODLINE PARTNERS LP | 05/15/2026 | 1.49 M | $5.57 M | 100.22% | 1.21% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 05/11/2026 | 1.42 M | $5.32 M | -1.10% | 1.16% |
| DEUTSCHE BANK AG\ | 05/06/2026 | 997.85 K | $3.74 M | 1.06% | 0.81% |
| ALDEBARAN CAPITAL, LLC | 05/07/2026 | 947.16 K | $3.55 M | -0.74% | 0.77% |
| D. E. SHAW & CO., INC. | 05/15/2026 | 900.80 K | $3.38 M | -57.04% | 0.73% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 756.13 K | $2.84 M | -28.21% | 0.62% |
| NORTHERN TRUST CORP | 05/14/2026 | 728.23 K | $2.73 M | 9.63% | 0.59% |
| THREE BRIDGE WEALTH ADVISORS, LLC | 05/12/2026 | 714.82 K | $2.68 M | 0.00% | 0.58% |
| MARSHALL WACE, LLP | 05/15/2026 | 712.98 K | $2.67 M | 46.86% | 0.58% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 628.86 K | $2.36 M | 100.00% | 0.51% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 588.69 K | $2.21 M | -6.93% | 0.48% |
| DIMENSIONAL FUND ADVISORS LP | 05/07/2026 | 511.46 K | $1.91 M | 88.84% | 0.42% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 502.63 K | $1.88 M | -55.33% | 0.41% |
| PANAGORA ASSET MANAGEMENT INC | 05/14/2026 | 502.29 K | $1.88 M | 636.60% | 0.41% |
| MONASHEE INVESTMENT MANAGEMENT LLC | 05/13/2026 | 500.00 K | $1.88 M | 100.00% | 0.41% |
| LOGOS GLOBAL MANAGEMENT LP | 05/15/2026 | 500.00 K | $1.88 M | -16.67% | 0.41% |
| JPMORGAN CHASE & CO | 05/13/2026 | 486.63 K | $1.70 M | -22.26% | 0.40% |
| CITADEL ADVISORS LLC | 05/15/2026 | 466.40 K | $1.75 M | -59.03% | 0.38% |
| AISLING CAPITAL MANAGEMENT LP | 05/05/2026 | 434.46 K | $1.63 M | 0.00% | 0.35% |
| BOLLARD GROUP LLC | 05/14/2026 | 431.63 K | $1.62 M | -46.34% | 0.35% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 395.64 K | $1.48 M | -31.10% | 0.32% |
| BIOIMPACT CAPITAL LLC | 05/15/2026 | 391.92 K | $1.47 M | 100.00% | 0.32% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 379.93 K | $1.42 M | -58.56% | 0.31% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 05/14/2026 | 366.49 K | $1.37 M | 100.00% | 0.30% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2026 | 330.02 K | $1.24 M | 0.00% | 0.27% |
| RUSSELL INVESTMENTS GROUP, LTD. | 05/08/2026 | 308.17 K | $1.16 M | 3,049.36% | 0.25% |
| HIGHTOWER ADVISORS, LLC | 05/05/2026 | 305.84 K | $1.15 M | -0.04% | 0.25% |
| RAYMOND JAMES FINANCIAL INC | 05/14/2026 | 266.45 K | $999.18 K | -1.20% | 0.22% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 260.99 K | $978.71 K | -8.30% | 0.21% |
| WELLINGTON MANAGEMENT GROUP LLP | 05/15/2026 | 257.16 K | $964.34 K | -2.72% | 0.21% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Aclaris Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 177 institutional investors and hedge funds held shares of Aclaris Therapeutics Inc. The most heavily invested institutionals were:
BML Capital Management, LLC: 14.25 M
Deep Track Capital, LP: 9.35 M
BlackRock, Inc.: 7.41 M
RA CAPITAL MANAGEMENT, L.P.: 6.8 M
Vivo Capital, LLC: 6.67 M
Frazier Life Sciences Management, L.P.: 4.93 M
88.63% of Aclaris Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 116.14 M shares in the last 24 months. This purchase volume represents approximately $393.71 M in transactions.